✦ LIBER ✦

Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension

✍ Scribed by Zhang, R; Thakur, V; Morse, S; Reisin, E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory Considerations for Manufactur

✍ Darin J. Weber 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 196 KB

Impact of the obesity epidemic on hypert

✍ John E. Hall; Daniel W. Jones; Jay J. Kuo; Alexandre da Silva; Lakshmi S. Tallam 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 338 KB

Molecular Basis of Obesity and the Risk

✍ Muhidien Soufi; Alexander M. Sattler; Matthias Herzum; Bernhard Maisch; Jürgen R 📂 Article 📅 2006 🏛 Urban and Vogel 🌐 German ⚖ 475 KB

The influences of hyperprolactinemia and

✍ Omar Serri; Ling Li; Jean-Claude Mamputu; Marie-Claude Beauchamp; Fritz Maingret 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

The influences of hyperprolactinaemia an

✍ Christoph Schmid; Michael Brändle 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Pharmacologic Considerations in Antimicr

✍ P.S. McKinnon; V.L. Yu 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 45 KB